SNPS vs VYNE · P/E 63, rev $7.16B vs rev $501.0K
Synopsys Inc (SNPS) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
SNPS currently screens at market cap $85.14B and trailing P/E 63.3. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the SNPS and VYNE stock pages for the full models.
Not investment advice.